Editorial

. 2019 Jan;28(1):93-97.

doi: 10.1080/13543784.2019.1552677. Epub 2018 Dec 1.

Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease

Antoni Camins^{1

2

3}, Miren Ettcheto^{1

2

3

4}, Oriol Busquets^{1

2

3

4}, Patricia R Manzine^{1

5}, Rubén Dario Castro-Torres^{1

6

7}, Carlos Beas-Zarate⁷, Ester Verdaguer^{2

3

6}, Francesc X Sureda⁴, Monica Bulló⁴, Jordi Olloquequi⁸, Carme Auladell^{2

3

6}, Jaume Folch^{2

4}

Affiliations

¹ a Departament de Farmacologia , Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona , Barcelona , Spain.
² b Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED) , Madrid , Spain.
³ c Institut de Neurociències, Universitat de Barcelona , Barcelona , Spain.
⁴ d Departament de Bioquímica i Biotecnologia , Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili , Reus , Spain.
⁵ e Department of Gerontology , Federal University of São Carlos (UFSCar) , São Carlos , Brazil.
⁶ f Departament de Biologia Cel·lular , Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona , Barcelona , Spain.
⁷ g Departamento de Biología Celular y Molecular , C.U.C.B.A., Universidad de Guadalajara y División de Neurociencias , Guadalajara , México.
⁸ h Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud , Universidad Autónoma de Chile , Talca , Chile.

PMID: 30480461
DOI: 10.1080/13543784.2019.1552677

Editorial

Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease

Antoni Camins et al. Expert Opin Investig Drugs. 2019 Jan.

. 2019 Jan;28(1):93-97.

doi: 10.1080/13543784.2019.1552677. Epub 2018 Dec 1.

Authors

Affiliations

¹ a Departament de Farmacologia , Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona , Barcelona , Spain.
² b Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED) , Madrid , Spain.
³ c Institut de Neurociències, Universitat de Barcelona , Barcelona , Spain.
⁴ d Departament de Bioquímica i Biotecnologia , Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili , Reus , Spain.
⁵ e Department of Gerontology , Federal University of São Carlos (UFSCar) , São Carlos , Brazil.
⁶ f Departament de Biologia Cel·lular , Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona , Barcelona , Spain.
⁷ g Departamento de Biología Celular y Molecular , C.U.C.B.A., Universidad de Guadalajara y División de Neurociencias , Guadalajara , México.
⁸ h Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud , Universidad Autónoma de Chile , Talca , Chile.

PMID: 30480461
DOI: 10.1080/13543784.2019.1552677

No abstract available

Keywords: Alzheimer’s disease; glucagon; glucagon-like peptide; glucose-dependent insulinotropic peptide; type 2 diabetes.

PubMed Disclaimer

Cited by

The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome.
Bednarz K, Kowalczyk K, Cwynar M, Czapla D, Czarkowski W, Kmita D, Nowak A, Madej P. Bednarz K, et al. Int J Mol Sci. 2022 Apr 14;23(8):4334. doi: 10.3390/ijms23084334. Int J Mol Sci. 2022. PMID: 35457152 Free PMC article. Review.
Alzheimer's disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links.
Rojas M, Chávez-Castillo M, Bautista J, Ortega Á, Nava M, Salazar J, Díaz-Camargo E, Medina O, Rojas-Quintero J, Bermúdez V. Rojas M, et al. World J Diabetes. 2021 Jun 15;12(6):745-766. doi: 10.4239/wjd.v12.i6.745. World J Diabetes. 2021. PMID: 34168725 Free PMC article. Review.
Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions.
English A, Irwin N. English A, et al. Clin Med Insights Endocrinol Diabetes. 2019 Dec 12;12:1179551419888871. doi: 10.1177/1179551419888871. eCollection 2019. Clin Med Insights Endocrinol Diabetes. 2019. PMID: 32425629 Free PMC article. Review.
The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer's Dementia.
Folch J, Olloquequi J, Ettcheto M, Busquets O, Sánchez-López E, Cano A, Espinosa-Jiménez T, García ML, Beas-Zarate C, Casadesús G, Bulló M, Auladell C, Camins A. Folch J, et al. Front Aging Neurosci. 2019 Sep 6;11:236. doi: 10.3389/fnagi.2019.00236. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31551756 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease

Affiliations

Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer's disease

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical